Key result
Female sex linked to ~58% higher 30-day VF risk versus males in fulminant myocarditis.
Why the study?
Data on sex differences in early ventricular fibrillation in patients with fulminant myocarditis were limited.
Does female sex increase the risk of early ventricular fibrillation in patients with fulminant myocarditis?
Cohort (n=696)
Yes
Does female sex increase the risk of early ventricular fibrillation in patients with fulminant myocarditis?
In patients with fulminant myocarditis, female sex is associated with a significantly higher risk of early ventricular fibrillation within 30 days of admission compared to male sex.
Answers are grounded in this paper and cite their sources.
May warrant closer VF monitoring in females with fulminant myocarditis; leaves open whether sex-specific strategies improve outcomes.
BACKGROUND: Fulminant myocarditis is a rare but life-threatening condition frequently complicated by malignant ventricular arrhythmias. Data on sex differences in early ventricular fibrillation (VF) in fulminant presentation are limited. METHODS: We conducted a retrospective nationwide multicentre cohort study using the Japanese Registry of Fulminant Myocarditis between 2012 and 2017. Fulminant presentation was defined as prodromal symptoms within 4 weeks and the need for catecholamines and/or mechanical circulatory support within 14 days of admission. The primary endpoint was VF within 30 days after admission. We estimated the 30-day cumulative incidence of VF and used Fine-Gray competing-risk regression (death as the competing event) to evaluate the association with sex. RESULTS: Among 696 patients (40% female), VF within 30 days occurred in 120 (17%). Female patients had a higher 30-day incidence of VF than male patients (22% vs 14%; p=0.006). In multivariable complete-case analysis adjusting for age, left ventricular ejection fraction on admission, estimated glomerular filtration rate and peak creatine kinase, female sex was associated with 30-day VF (subdistribution HR, 1.58; 95% CI 1.09 to WHAT IS ALREADY KNOWN ON THIS TOPIC2.28; p=0.016). Ninety-day all-cause mortality was 36% in female patients and 34% in male patients (p=0.732). CONCLUSIONS: In a nationwide registry of fulminant myocarditis, female sex was associated with a higher risk of early VF, whereas there was no clear evidence of a sex difference in 90-day all-cause mortality. Incorporating sex into early risk assessment may help tailor acute monitoring and management strategies in this high-risk condition.
No takes yet. Share an insight, caveat, or question.
Moriwaki et al. (2026) conducted a cohort in fulminant myocarditis (n=696). Female sex vs. Male sex was evaluated on Ventricular fibrillation (VF) within 30 days after admission (HR 1.58, 95% CI 1.09-2.28, p=0.016). Among patients with fulminant myocarditis, female sex was associated with a higher 30-day risk of ventricular fibrillation compared to male sex.
Synapse has enriched 10 related papers. Consider them for comparative context: